Weekly Trend BriefEvidence window ending 2026-05-25

Gut Microbiota and Health

Gut Microbiota and Health has 1,104 eligible papers in the latest 30-day evidence window, up 22% from the prior window, with representative work spanning Taxonomic and functional remodeling of the gut microbiota during aging and implications for microbiota-derived biomarkers; Identifying microbial biomarkers of neurodegeneration: a comparative study in Alzheimer’s and Parkinson’s disease; Clinical significance of gut microbiota-derived metabolite trimethylamine N-oxide in patients with systemic lupus erythematosus.

Gut Microbiota and Health shows 1,104 eligible recent papers and 1,100 commentary-ready papers in the current 30-day window, compared with 904 eligible papers in the prior window. The strongest evidence comes from 1 visible topic cluster and 8 representative papers. Several representative papers may be preprints, so this brief treats them as emerging signals rather than settled consensus.

1,104Recent 30-day eligible papers
904Prior 30-day eligible papers
1,100Commentary-ready papers
8Representative papers surfaced
Current windowRecent eligible papers
ComparisonPrior eligible papers
Brief typeWeekly research trend
Evidence-backed changes

What's moving

1
Change

Recent publication activity has a clear weekly signal

Gut Microbiota and Health recorded 1,104 eligible papers in the latest 30-day window, compared with 904 in the prior 30-day window, making the current snapshot up 22% from the prior window.

1,104 recent vs 904 prior eligible papers
2
Change

Gut microbiota and health anchors the current evidence

Gut microbiota and health contributes 1,104 eligible recent papers, including 1,100 papers with abstracts available for commentary.

1,104 papers in the leading cluster
3
Change

Representative papers show where the activity is concentrated

The representative set includes Taxonomic and functional remodeling of the gut microbiota during aging and implications for microbiota-derived biomarkers; Identifying microbial biomarkers of neurodegeneration: a comparative study in Alzheimer’s and Parkinson’s disease; Clinical significance of gut microbiota-derived metabolite trimethylamine N-oxide in patients with systemic lupus erythematosus; Reframing obesity through the gut microbiota: functional dysbiosis and metabolic disease; and other recent papers. These papers anchor the page's claims and keep the brief tied to visible evidence.

8 representative papers
Topic shape

Theme clusters

Gut microbiota and health

Gut microbiota and health accounts for 1,104 eligible recent papers, including 1,100 commentary-ready papers in this evidence window.

1,104 recent eligible papers

Representative papers to review

The selected papers cover Taxonomic and functional remodeling of the gut microbiota during aging and implications for microbiota-derived biomarkers; Identifying microbial biomarkers of neurodegeneration: a comparative study in Alzheimer’s and Parkinson’s disease; Clinical significance of gut microbiota-derived metabolite trimethylamine N-oxide in patients with systemic lupus erythematosus; Reframing obesity through the gut microbiota: functional dysbiosis and metabolic disease.

8 representative papers
Evidence anchors

Representative papers

Gut microbiota and healtharticle

The human gut microbiome across the life course

A recent paper from FEBS Letters in the Gut microbiota and health evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.

FEBS Letters · 2026